These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2399883)

  • 61. Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction.
    Rodriguez LM; Oyarzun R; Smeets J; Brachmann J; Schmitt C; Brugada P; Geelen P; Lipcsei G; Albert A; Wellens HJ
    Am J Cardiol; 1992 Feb; 69(5):462-4. PubMed ID: 1736607
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands.
    Willems AR; Tijssen JG; van Capelle FJ; Kingma JH; Hauer RN; Vermeulen FE; Brugada P; van Hoogenhuyze DC; Janse MJ
    J Am Coll Cardiol; 1990 Sep; 16(3):521-30. PubMed ID: 2201710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Results of electrophysiologically guided operations for drug-resistant recurrent ventricular tachycardia and ventricular fibrillation due to coronary artery disease.
    Brodman R; Fisher JD; Johnston DR; Kim SG; Matos JA; Waspe LE; Scavin GM; Furman S
    J Thorac Cardiovasc Surg; 1984 Mar; 87(3):431-8. PubMed ID: 6700249
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapy for late post infarction ventricular tachycardia.
    Somberg JC; Butler B; Torres V; Tepper D; Keren G; Siegel L; Jentzer J; Miura DS
    Angiology; 1985 Mar; 36(3):181-90. PubMed ID: 3896040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
    Capparelli EV; Kluger J; Regnier JC; Chow MS
    J Clin Pharmacol; 1988 Mar; 28(3):268-75. PubMed ID: 3129456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
    Morady F; Scheinman MM; Hess DS; Sung RJ; Shen E; Shapiro W
    Am J Cardiol; 1983 Jan; 51(1):85-9. PubMed ID: 6849269
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
    Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB
    Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
    Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
    Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
    Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of chronic amiodarone therapy on ventricular tachycardia induced by programmed ventricular stimulation.
    DiCarlo LA; Morady F; de Buitleir M; Baerman JM; Schurig L; Annesley T
    Am Heart J; 1987 Jan; 113(1):57-64. PubMed ID: 3799442
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Value of serial electropharmacological testing in managing patients resuscitated from cardiac arrest.
    Raviele A; Di Pede F; Delise P; Piccolo E
    Pacing Clin Electrophysiol; 1984 Sep; 7(5):850-60. PubMed ID: 6207498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring.
    Skale BT; Miles WM; Heger JJ; Zipes DP; Prystowsky EN
    Am J Cardiol; 1986 Jan; 57(1):113-9. PubMed ID: 3942053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator.
    Manolis AS; Tan-DeGuzman W; Lee MA; Rastegar H; Haffajee CI; Huang SK; Estes NA
    Am Heart J; 1989 Sep; 118(3):445-50. PubMed ID: 2773768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing.
    Roy D; Waxman HL; Kienzle MG; Buxton AE; Marchlinski FE; Josephson ME
    Am J Cardiol; 1983 Nov; 52(8):969-74. PubMed ID: 6637850
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y; Paul VE; Griffith MJ; Sneddon JF; Farrell TG; Ward DE; Camm AJ
    Am Heart J; 1992 Nov; 124(5):1233-40. PubMed ID: 1442491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.